Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
JWK-006 by Chengdu Genevector Biotechnology for Juvenile Macular Degeneration (Stargardt Disease): Likelihood of Approval
JWK-006 is under clinical development by Chengdu Genevector Biotechnology and currently in Phase II for Juvenile Macular Degeneration (Stargardt Disease)....